NicOx S.A announced to have been successful in the second phase 3 study for naproxcinod in 1020 patients with osteoarthritis of the knee. It has also met the main secondary endpoint, demonstrating that naproxcinod 750 mg bid was statistically non-inferior to naproxen 500 mg bid on the WOMAC(TM) pain and function subscales at week-13 and [...]
On Monday,14 of July, 2008 the company Amgen announced that an experimental drug Denosumab could reduce the risk of osteoporosis and fracture in men who were treated with prostate cancer medicines that is associated with bone loss.
According to the Canadian researchers patients with Scheleroderma (systemic sclerosis) have higher chance of developing Osteoporosis similar to those in patients with rheumatoid arthritis(RA).
 |  |  |  |  |  |  |
 |  |  |  |  |  |  |
 |  |  |  |  |  |  |
 |  |  |  |  |  |  |
 |  |  |  |  | ||
| Plugin by Taragana | ||||||
You are currently browsing the archives for the Osteoporosis category.
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Oct | ||||||
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |